Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

INTRODUCTION: Down syndrome (DS) is associated with an almost universal development of Alzheimer's disease. Individuals with DS are therefore an important population for randomized controlled trials to prevent or delay cognitive decline, though it is essential to understand the time course of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Startin, Carla M., Hamburg, Sarah, Hithersay, Rosalyn, Al-Janabi, Tamara, Mok, Kin Y., Hardy, John, Strydom, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Inc 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374283/
https://www.ncbi.nlm.nih.gov/pubmed/30503169
http://dx.doi.org/10.1016/j.jalz.2018.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374283/
https://www.ncbi.nlm.nih.gov/pubmed/30503169
http://dx.doi.org/10.1016/j.jalz.2018.08.009

Ejemplares similares